Sentinel lymph node radiolocalization in clinically negative neck oral cancer

Akihiro Terada1, Yasuhisa Hasegawa, Mitsuo Goto

  • 1Department of Head and Neck Surgery, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa-ku, Nagoya, Aichi 464-8681 Japan.

Head & Neck
|September 13, 2005
PubMed
Abstract

Insights

Sentinel lymph node (SLN) biopsy is a reliable method for staging oral cancer. Analyzing the three hottest SLNs accurately predicts neck status, sparing unnecessary surgeries.

Area of Science:

  • Oncology
  • Nuclear Medicine
  • Head and Neck Surgery

Background:

  • The sentinel lymph node (SLN) concept is a key area of interest in head and neck cancer treatment.
  • This study evaluates the feasibility and clinical application of SLN radiolocalization and biopsy in patients with clinically negative neck oral cancer.

Purpose of the Study:

  • To assess the feasibility of SLN radiolocalization and biopsy in oral cancer patients.
  • To evaluate the clinical application and diagnostic accuracy of SLN biopsy in determining neck status.

Main Methods:

  • Feasibility study involving 15 patients with N0 oral cancer using 99m Tc phytate tracer.
  • Clinical application in 12 patients using SPECT/CT fusion imaging for intraoperative SLN biopsy (SLNB).
  • Comparison of multi-slice frozen section analysis and imprint cytology for intraoperative SLNB diagnosis.

Main Results:

  • SLN concept established; radioactivity accurately reflected neck status.
  • Intraoperative diagnosis of the three hottest SLNs predicted neck status in 10 of 12 patients.
  • Multi-slice frozen section analysis outperformed imprint cytology for intraoperative SLNB diagnosis.

Conclusions:

  • SLN concept is validated in the head and neck region.
  • Analysis of the three hottest SLNs is sufficient for predicting patient neck status.
  • Intraoperative SLNB using SPECT/CT fusion imaging is accurate and reliable for managing oral cancer.

Related Concept Videos